COEPTIS THERAPEUTICS
Coeptis Therapeutics focuses on the development and acquisition of pharmaceutical products. Coeptis’ pipeline is evolving from the partnerships being created with multiple pharmaceutical companies currently. As these relationships unfold, the product pipeline will be updated accordingly.
COEPTIS THERAPEUTICS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Address:
Wexford, Pennsylvania, United States
Country:
United States
Website Url:
http://www.coeptistx.com
Status:
Active
Contact:
1 (724) 934-6467
Email Addresses:
[email protected]
Total Funding:
5.52 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Font Awesome Global Site Tag
Similar Organizations
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Caret Pharma
Caret Pharma research, development and marketing of nonprescription products.
Covenant Animal Health Partners
Covenant Animal Health Partners is dedicated to the development and registration of “revenue-ready” animal health products.
Laboratorios Brovel
Laboratorios Brovel is the production and distribution of pharmaceutical veterinary products.
Martin Innovations
Martin Innovations is focused on the development of safe patient handling solutions and bariatric care products.
Mekanistic Therapeutics
Mekanistic Therapeutics focuse on the development of cancer therapeutics.
Nazura Biohealth
Nazura Biohealth is formed by Elcelyx Therapeutics to focus on the development of Gut Sensory Modulators (GSM) and the product Lovidia.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Current Employees Featured
Founder
Official Site Inspections
http://www.coeptistx.com Semrush global rank: 4.41 M Semrush visits lastest month: 2.52 K
- Host name: 136.25.174.34.bc.googleusercontent.com
- IP address: 34.174.25.136
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Coeptis Therapeutics"
About - Coeptis Therapeutics
Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), together with its subsidiaries (including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals, Inc., (collectively “Coeptis”), is a …See details»
Coeptis Therapeutics Holdings, Inc. Corporate Overview
1 © 2023 Coeptis Therapeutics Holdings, Inc. All rights reserved Coeptis Therapeutics Holdings, Inc. Corporate Overview NASDAQ: COEP C10050 V7.0 April-2024See details»
Coeptis Therapeutics - Crunchbase Company Profile & Funding
Coeptis Therapeutics has successfully closed on $4.3 million of Series A Preferred Offering. Additionally, the company announced its participation in significant industry events, including a …See details»
Coeptis Therapeutics Investor Relations - Company
Dec 6, 2023 Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), together with its subsidiaries (including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals, Inc., …See details»
COEP - Coeptis Therapeutics Holdings Inc. - OTC Markets
3 days ago www.coeptistx.com. 724-934-6467. [email protected]. Business Description. Coeptis Therapeutics Holdings, Inc., together with its subsidiaries (including …See details»
Coeptis Therapeutics Holdings, Inc. (COEP) - Yahoo Finance
See the company profile for Coeptis Therapeutics Holdings, Inc. (COEP) including business summary, industry/sector information, number of employees, business summary, corporate …See details»
Company Information - RocketReach
Coeptistx.com; 5+ 724625XXXX; 412398XXXX; 724625XXXX; 724630XXXX; 865483XXXX; 412630XXXX; Brian Cogley Chief Financial Officer at Coeptis Therapeutics Cranberry …See details»
Coeptis Therapeutics Company Profile | Management and
[email protected]: Coeptis Therapeutics Top Competitors. Company Employees Revenue Top technologies; Alamab Therapeutics. 17: $3.8 M: Dunad Therapeutics. 21: $2.1 M: …See details»
Coeptis Therapeutics - Overview, News & Similar companies
May 17, 2023 Coeptis Therapeutics has announced that Brian Cogley has joined the organization as Chief Financial Officer. Previously, Cogley served as Senior Manager & …See details»
Coeptis Therapeutics - LinkedIn
Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) is a biopharmaceutical company developing innovative cell therapy platforms for patients with cancer.See details»
Coeptis Therapeutics Holdings, Inc. (COEP) - Yahoo Finance Canada
See the company profile for Coeptis Therapeutics Holdings, Inc. (COEP) including business summary, industry/sector information, number of employees, business summary, corporate …See details»
Overview - Coeptis Therapeutics
Coeptis Therapeutics Holdings, Inc. Corporate Headquarters 105 Bradford Road, Suite 420 Wexford, PA 15090 +1 (724) 934-6467 [email protected]See details»
Company Description - Stock Analysis
6 days ago Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical company. It is developing cell therapy platforms for cancer, autoimmune, …See details»
Coeptis Therapeutics President and CEO Issues Letter to …
WEXFORD, Pa., Jan. 4, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company developing innovative cell …See details»
Coeptis Therapeutics Inc Overview - Salary.com
Discover essential details about Coeptis Therapeutics Inc, including address, contact, and journey of our company's evolution.See details»
Coeptis Therapeutics Holdings, Inc. (COEP) - Stock Analysis
2 days ago About COEP. Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical company. It is developing cell therapy platforms for cancer, …See details»
Coeptis Therapeutics President and CEO Issues Letter to …
Jan 4, 2024 Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company developing innovative cell therapy platforms for …See details»
Coeptis Therapeutics Secures Exclusive Rights to Negotiate to …
Mar 29, 2023 Potential acquisition of VyGen-Bio would strengthen Coeptis' oncology pipeline by obtaining exclusive, worldwide ownership rights to GEAR™ Platform and companion …See details»
Novel Cell Therapies Strategy - Coeptis Therapeutics
Through this novel platform, notch mediated CD34+ cell expansion and direction differentiation allow for NK cells to be produced with improved lot-to-lot consistency, and with greater …See details»